Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action
- PMID: 38504384
- PMCID: PMC10949674
- DOI: 10.1186/s13722-024-00448-8
Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action
Abstract
Alcohol-associated liver disease is currently the leading cause of liver transplantation and liver deaths both in Europe and the United States. Efficacious treatments exist for alcohol use disorder, but they are seldomly prescribed for patients who need them. Besides, the presence of liver cirrhosis can complicate pharmacological treatment choices. In this review, we discuss established and innovative treatment strategies to treat unhealthy alcohol use in patients with alcohol-associated liver disease. We also describe the experience of our own institutions, Hospital Universitari Germans Trias i Pujol in Badalona (Spain) and Yale-New Haven Health and Yale Medicine (Connecticut. United States of America).
Keywords: Addiction medicine; Alcohol use disorder; Alcohol-associated liver disease; Hepatology; Treatment.
© 2024. The Author(s).
Conflict of interest statement
None to disclose.
Figures
Similar articles
-
Closing the Care Gap: Management of Alcohol Use Disorder in Patients with Alcohol-associated Liver Disease.Clin Ther. 2023 Dec;45(12):1189-1200. doi: 10.1016/j.clinthera.2023.09.017. Epub 2023 Dec 4. Clin Ther. 2023. PMID: 38052695 Free PMC article. Review.
-
Covid-19 and alcohol associated liver disease.Dig Liver Dis. 2022 Nov;54(11):1459-1468. doi: 10.1016/j.dld.2022.07.007. Epub 2022 Aug 4. Dig Liver Dis. 2022. PMID: 35933291 Free PMC article. Review.
-
Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy.Semin Liver Dis. 2022 May;42(2):138-150. doi: 10.1055/a-1798-2872. Epub 2022 Mar 15. Semin Liver Dis. 2022. PMID: 35292951 Review.
-
Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder.Clin Gastroenterol Hepatol. 2023 Jul;21(8):2124-2134. doi: 10.1016/j.cgh.2023.02.017. Epub 2023 Feb 27. Clin Gastroenterol Hepatol. 2023. PMID: 36858144 Review.
-
Alcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinence.World J Gastroenterol. 2015 Jul 28;21(28):8516-26. doi: 10.3748/wjg.v21.i28.8516. World J Gastroenterol. 2015. PMID: 26229395 Free PMC article. Review.
Cited by
-
Demographic and clinical characteristics associated with utilization of alcohol use disorder treatment in a multicenter study of patients with alcohol-associated cirrhosis.Alcohol Clin Exp Res (Hoboken). 2025 Jan;49(1):244-255. doi: 10.1111/acer.15500. Epub 2024 Dec 4. Alcohol Clin Exp Res (Hoboken). 2025. PMID: 39632077
-
The urgent need for multidisciplinary approaches in managing alcohol-associated liver disease: Editorial on "The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study".Clin Mol Hepatol. 2025 Jan;31(1):316-318. doi: 10.3350/cmh.2024.0847. Epub 2024 Oct 7. Clin Mol Hepatol. 2025. PMID: 39370717 Free PMC article. No abstract available.
-
Culturally tailored steatotic liver disease management: Latino and Asian community partner perspectives and recommendations.Hepatol Commun. 2025 Jun 9;9(7):e0749. doi: 10.1097/HC9.0000000000000749. eCollection 2025 Jul 1. Hepatol Commun. 2025. PMID: 40489763 Free PMC article.
-
Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease.Aliment Pharmacol Ther. 2025 Feb;61(3):481-490. doi: 10.1111/apt.18387. Epub 2024 Nov 11. Aliment Pharmacol Ther. 2025. PMID: 39523996
-
Real-world analysis on the use of gamma-hydroxybutyric acid for alcohol withdrawal syndrome in hospitalized patients with diagnosis of cirrhosis.Intern Emerg Med. 2025 Jan;20(1):119-129. doi: 10.1007/s11739-024-03761-x. Epub 2024 Sep 9. Intern Emerg Med. 2025. PMID: 39249626 Free PMC article.
References
-
- Grant BF, Chou SP, Saha TD, et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001–2002 to 2012–2013: results from the national epidemiologic survey on alcohol and related conditions. JAMA Psychiat. 2017;74(9):911–923. doi: 10.1001/JAMAPSYCHIATRY.2017.2161. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous